Long-term real-world outcomes of retinal microvasculature changes in proliferative diabetic retinopathy treated with panretinal photocoagulation vs. intravitreal conbercept

被引:3
|
作者
Li, Zijing [1 ,2 ]
Zhou, Lijun [1 ]
Huang, Chuangxin [1 ]
Lu, Tu [1 ]
Liang, Jiandong [1 ]
Cong, Qifeng [1 ]
Lan, Yuqing [2 ]
Jin, Chenjin [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, 107 Yanjiang West Rd, Guangzhou 510020, Peoples R China
[3] 54 South Xianlie Rd, Guangzhou 510060, Peoples R China
关键词
Long-term; Real; -world; Optical coherence tomography angiography; Proliferative diabetic retinopathy; Panretinal photocoagulation; Conbercept;
D O I
10.1016/j.mvr.2023.104586
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose: To compare long-term real-world outcomes of retinal microvasculature changes in proliferative diabetic retinopathy (PDR) treated with panretinal photocoagulation (PRP) vs. intravitreal conbercept (IVC) and to explore the potential factors affecting these changes.Methods: This study retrospectively included 96 treatment-naive PDR eyes of 96 type 2 diabetes mellitus patients [59 PRP and 37 IVC]. Baseline characteristics and treatment details were collected. Optical coherence tomography angiography (OCTA) data of macular vessel density (VD) and optic disc capillary density (CD) at baseline and at the last follow-up were compared between groups. The differences between the baseline and the last follow-up OCTA data in each group were also tested for significance. The correlation between the change in each OCTA parameter from baseline and each baseline characteristic/treatment parameter was investigated in each group. Results: During a mean follow-up of two years, greater superficial (SCP) (p = 0.004) and deep capillary plexus (DCP) VD (p < 0.001) were observed in the foveal area in the PRP than in the IVC. Compared to the baseline, SCP VD in the foveal area increased in the PRP (p = 0.012), while an increased SCP VD in some sectors in the parafoveal and perifoveal areas (p < 0.05), rather than the foveal area (p = 0.908), was seen in the IVC. For both groups, eyes with a higher VD/CD at baseline tended to develop capillary dropout more intensively (all p < 0.05). In the IVC group, foveal avascular zone (FAZ) area change showed a negative correlation with baseline FAZ area (p = 0.020), and complementary PRP exerted a negative influence on FAZ area change (p = 0.002). In the PRP group, SCP VD change was positively correlated with follow-up frequency, and was negatively correlated with diastolic blood pressure (all p < 0.05); DCP VD change showed a positive correlation with PRP shot number (p = 0.019).Conclusion: The aforementioned microvasculature changes should be considered when PRP or IVC is adopted in PDR long-term management.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] LONG-TERM TEMPORAL CHANGES OF PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS BEFORE AND AFTER PANRETINAL PHOTOCOAGULATION IN SEVERE DIABETIC RETINOPATHY
    Kim, Jongshin
    Woo, Se Joon
    Ahn, Jeeyun
    Park, Ki Ho
    Chung, Hum
    Park, Kyu Hyung
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (10): : 2052 - 2060
  • [22] LONG-TERM STABILITY AND VISUAL OUTCOME AFTER FAVORABLE INITIAL RESPONSE OF PROLIFERATIVE DIABETIC-RETINOPATHY TO PANRETINAL PHOTOCOAGULATION
    VANDER, JF
    DUKER, JS
    BENSON, WE
    BROWN, GC
    MCNAMARA, JA
    ROSENSTEIN, RB
    OPHTHALMOLOGY, 1991, 98 (10) : 1575 - 1579
  • [23] Long-term effects of anti-VEGF therapy versus panretinal photocoagulation (PRP) on retinal vessel caliber in eyes with proliferative diabetic retinopathy (PDR)
    Shen, Steven
    Josic, Kristin L.
    Pak, Jeong W.
    Meuer, Stacy
    Domalpally, Amitha
    Blodi, Barbara A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [24] Outcomes in proliferative diabetic retinopathy patients who are lost to follow-up after panretinal photocoagulation vs. intravitreal anti-vascular endothelial growth factor injection
    Hsu, Jason
    Obeid, Anthony
    Su, Daniel
    Uhr, Joshua
    Patel, Samir N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [25] Long-term Changes in the Peripapillary RNFL and Macular GCIPL Thicknesses after Panretinal Photocoagulation in Diabetic Retinopathy Patients
    Yoon, Jung Hyun
    Park, Dong Ho
    Kim, Dai Woo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2018, 59 (10): : 938 - 945
  • [26] Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
    Johanna J. Zirpel
    Isabel B. Pfister
    Christin Gerhardt
    Justus G. Garweg
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 3569 - 3578
  • [27] Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
    Zirpel, Johanna J.
    Pfister, Isabel B.
    Gerhardt, Christin
    Garweg, Justus G.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (12) : 3569 - 3578
  • [28] Long-term effects of panretinal photocoagulation (PRP) vs intravitreal ranibizumab (IVR) on OCT-measured choroidal thickness, and retinal thickness and integrity
    Lee, Brian
    Josic, Kristin L.
    Nittala, Muneeswar Gupta
    Karamat, Ayesha Nuri
    Corvi, Federico
    Singh, Gagan
    Sadda, Srinivas R.
    Ip, Michael S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [29] Outcomes of neovascular glaucoma secondary to proliferative diabetic retinopathy treated with surgical therapies in real-world clinical setting
    Miyao, Kenji
    Kanda, Takayuki
    Harimoto, Kozo
    Okazawa, Rina
    Kitamura, Riki
    Sato, Tomohito
    Takeuchi, Masaru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [30] Long-Term Visual Function Effects of Pan-Retinal Photocoagulation in Diabetic Retinopathy and Its Impact in Real Life
    Baptista, Pedro Manuel
    Marta, Ana Ambrosio
    Heitor, Joao
    Jose, Diana
    Almeida, Daniel
    Ribeiro, Antonio
    Barbosa, Irene
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1281 - 1293